| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3287183
Max Phase: Preclinical
Molecular Formula: C15H13FN2O
Molecular Weight: 256.28
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC(=O)N1CCc2cc(-c3cncc(F)c3)ccc21
Standard InChI: InChI=1S/C15H13FN2O/c1-10(19)18-5-4-12-6-11(2-3-15(12)18)13-7-14(16)9-17-8-13/h2-3,6-9H,4-5H2,1H3
Standard InChI Key: JMIFAUSTXBALDI-UHFFFAOYSA-N
Associated Targets(Human)
Cytochrome P450 11B2 2325 Activities
Cytochrome P450 11B1 1750 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Cytochrome P450 17A1 3627 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Cytochrome P450 19A1 6099 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 256.28 | Molecular Weight (Monoisotopic): 256.1012 | AlogP: 2.80 | #Rotatable Bonds: 1 |
| Polar Surface Area: 33.20 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 2.32 | CX LogP: 1.69 | CX LogD: 1.69 |
| Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.79 | Np Likeness Score: -1.57 |
References
| 1. Yin L, Hu Q, Emmerich J, Lo MM, Metzger E, Ali A, Hartmann RW.. (2014) Novel pyridyl- or isoquinolinyl-substituted indolines and indoles as potent and selective aldosterone synthase inhibitors., 57 (12): [PMID:24899257] [10.1021/jm500140c] |
Source
Source(1):